US2017035941A1PendingUtilityA1
Mineralization and Biological Modification of Biomaterial Surfaces
Est. expiryMar 19, 2019(expired)· nominal 20-yr term from priority
A61L 27/50A61L 27/56A61L 27/58A61L 27/18A61L 27/00A61L 27/44A61L 27/306A61L 2400/18A61L 2430/02
64
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Disclosed are advantageous methods for patterning and/or mineralizing biomaterial surfaces. The techniques described are particularly useful for generating three-dimensional or contoured bioimplant materials with patterned surfaces or patterned, mineralized surfaces. Also provided are various methods of using the mineralized and/or patterned biomaterials in tissue engineering, such as bone tissue engineering, providing more control over ongoing biological processes, such as mineralization, growth factor release, cellular attachment and tissue growth.
Claims
exact text as granted — not AI-modified1 . A method for mineralizing a biomaterial surface, comprising:
functionalizing at least a first inner pore surface of a biomaterial, wherein the biomaterial comprises at least a first porous, biodegradable polymer portion having an interconnected pore structure; and contacting the at least first inner pore surface of the biomaterial with an amount of a mineral-containing solution effective to form a mineralized biomaterial, wherein the mineralized biomaterial comprises a mineral coating at the functionalized at least first inner pore surface of the biomaterial.
2 . The method of claim 1 , wherein the functionalizing results from the contacting of the at least first inner pore surface of the biomaterial with the mineral-containing solution.
3 . The method of claim 1 , further comprising preparing at least a first portion of the biomaterial by a process comprising heating a biodegradable polymer.
4 . The method of claim 3 , wherein the biodegradable polymer is heated in a heat pressing process.
5 . The method of claim 1 , wherein the mineralized biomaterial is degradable over a controllable time scale.
6 . The method of claim 1 , wherein the polymer portion of the biomaterial is a poly(alpha-hydroxy) acid.
7 . The method of claim 1 , wherein the functionalizing of the at least first inner pore surface of the biomaterial creates a plurality of polar oxygen groups on the at least first inner pore surface of the biomaterial.
8 . The method of claim 1 , wherein said mineral coating is osteoconductive.
9 . The method of claim 1 , wherein the biomaterial is associated with a biologically effective amount of at least a first bioactive substance or biological cell.
10 . The method of claim 1 , wherein the functionalizing results from exposure to at least one of electromagnetic radiation, UV radiation, electron beam irradiation, or one or more functionalizing biocompatible chemicals.
11 . The method of claim 10 , wherein the one or more functionalizing biocompatible chemicals is an effective amount of NaOH.
12 . The method of claim 1 , further comprising
controlling mineralization of the at least first inner pore surface by at least one of
altering a molecular weight of the polymer, altering a composition of the polymer, altering a ratio of components within the polymer, altering the fabrication technique of the polymer, or altering the inner pore surface properties of the polymer, prior to contacting the at least first inner pore surface with the mineral-containing solution.
13 . A biomaterial, comprising:
a porous, biodegradable polymer portion having an interconnected pore structure; an inner pore surface; and a mineral coating at the inner pore surface of the biomaterial.
14 . The biomaterial of claim 13 , wherein the biodegradable polymer is poly(alpha-hydroxy) acid.
15 . The biomaterial of claim 13 , wherein the inner pore surface of the biomaterial is exposed to a functionalizing pre-treatment to create a functionalized inner pore surface.
16 . The biomaterial of claim 15 , wherein the functionalizing pre-treatment comprises contacting the biomaterial surface with an amount of a mineral-containing solution.
17 . The biomaterial of claim 13 , wherein the mineral coating is formed by contacting the biomaterial surface with an amount of a mineral-containing solution.
18 . The biomaterial of claim 13 , wherein the biomaterial is part of a 3-dimensional biomaterial scaffold.
19 . The biomaterial of claim 13 , wherein the biomaterial is associated with a biologically effective amount of at least a first bioactive substance or biological cell.
20 . The biomaterial of claim 13 , wherein said biodegradable polymer biomaterial is a poly(alpha-hydroxy) acid.
21 . The biomaterial of claim 13 , wherein the mineral coating is degradable over a controllable time scale.
22 . The biomaterial of claim 13 , wherein the mineral coating comprises an extended, mineral coating at the functionalized inner pore surface of the biomaterial.
23 . The biomaterial of claim 15 , wherein the functionalized inner pore surface comprises a plurality of polar oxygen groups on the inner pore surface.
24 . The biomaterial of claim 13 , wherein the mineral coating is osteoconductive.Join the waitlist — get patent alerts
Track US2017035941A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.